chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Red, hard circle at site of injection. Warm to touch. Pt has slight fever and headache. Pt seen family Dr today (12/7/15) who said it is infected.
This spontaneous report as received from a nurse refers to an unknown number of patients. No further information regarding the patients was available. On an unknown date the patients were vaccinated with improperly stored MMR II. Strength, dose, route and lot number were not provided. MMR II was exposed to a temperature between 46.5F and a highest of 48F for a total of 45 hours and 5 minutes from 10-APR-2014 to 02-MAY-2014: Out of range for 2 hours from 10-APR-2014 to 11-APR-2014; out of range for 10 hours and 15 minutes on 12-APR-2014; out of range for 12 hours and 25 minutes on 13-APR-2014; out of range for 1.5 hours on 14-APR-2014; out of range for 9.5 hours on 01-MAY-2014; out of range for 9 hours and 25 minutes on 02-MAY-2014. No adverse effects were reported. Follow up information has been received from two registered nurse (R.N.) reported that a 1 year old patient (gender not reported) who on an unknown date in 2014 received the MMR II (lot # reported as J004210 expiration 12-APR-2015; lot# J007155 expiration 20-JUN-2015) (the R.N. was unable to break out per Lot number of vaccine) (dose and route not reported) that had a temperature excursion and were found to be unstable. The MMR II was unstable after 12-APR-2014. The registered nurse stated that the patient needed to be contacted for re-vaccination. This is one of several reports received from the same reporter (other case IDs: 1405USA004214, 1405USA004215, 1405USA002823, from 1405USA012477 to 1405USA012482 and 1405USA004216). Additional information has been requested.
On 4/9, let eye turned red along with burning, itching, swelling, tearing  in the eye. Swelling in the armpit.  On 4/11, the pain in the eye became quite severe. Eye was also sensitive to light and touch. On 4/13, elevated ESR levels (67) were detected and Prednisone (60mg daily) s was prescribed. On 4/14, optometrist diagnosed iritis and prescribed Prednisone eye drops. On 4/19, further tests ruled out other possible causes for iritis and Prednisone was stopped.
Vaccine was expired on 09-NOV-2021 and administered on 10-NOV-2021/ expired vaccine was administered after the 30-day Use By Date or after manufacturer date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 09-NOV-2021 and administered on 10-NOV-2021/ expired vaccine was administered after the 30-day Use By Date or after manufacturer date of expiration) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 09-NOV-2021 and administered on 10-NOV-2021/ expired vaccine was administered after the 30-day Use By Date or after manufacturer date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 09-NOV-2021 and administered on 10-NOV-2021/ expired vaccine was administered after the 30-day Use By Date or after manufacturer date of expiration) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was reported.  Date the vial was initially stored in the refrigerator reported as unknown. Number of doses/vials was reported as 168 doses.   The vial did not undergo any temperature excursions.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow-up received contains non significant information.
Patient received anthrax(#1), Japanese encephalitis(#1) and typhoid(booster) on 16 March 2018. Patient called staff on 22 March 2018 regarding non-itchy bumps on both arms (upper arm down to wrists) and a slight itch in his throat. Patient notice the symptoms day after vaccinations on 17 March 2018 but disregarded the symptoms thinking they would subside in a day or two. Patient did not report any other concerns. Staff contacted DHA services Nurse Practitioner whom is reaching out to Patient for further guidance.
Patient called on 26 Sept to report that 4 hours after vaccine on 20 Sept she developed throat and lip swelling, facial itcing and congestion. She took Zyrtec at time of symptoms and 3 hours later with resolution of the problem. Never sought medical care.  No problems since.
Patient reported about 6 PM on evening that he received his flu vaccine his stomach started feeling upset, about 12:40 am on 10-23-10 he started to vomit alot lasted approximately 5 minutes.  After this initial vomiting episode he had 2 more vomiting episodes which he describes as minimal lasting a few minutes at the most.  Patient reported had similar reaction to the flu vaccine last year.  Patient reports he is a strict vegan and last time he ate eggs was about 25 years ago and had no reaction.  Denies allergies to latex.  Recommended allergy testing.
Left eye was swollen for 1 day. 2 days later right eye was swollen.  Later that night right eye went down and right cheek and lip were swollen.  From start to finish the swelling lasted 5 days.
shoulder, feels like someone is constantly sticking you with needles/pain in left arm and shoulder; The Left arm pain started on the same day as receiving the second dose; pain; It feels like someone is injecting him with a needle all over again whenever he  tries to sleep on left side or raise the arm over his head; it's very difficult to sleep on the left side or move arm up and down; pain in left arm and shoulder was reported as worsened.; soreness; This is a spontaneous report from a contactable consumer (patient). A 63-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number: ED7534, Expiry date: 30Jun2021, age at vaccination 63-year-old), via an unspecified route of administration, administered in left arm on 24Mar2021 as dose 2, single for covid-19 immunisation. Medical history included high blood pressure, allergy, allergy to dust, pollen, and environment allergies. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection Batch/Lot number: EN6205, Expiry date: 30Jun2021, at the age of 63-year-old), via an unspecified route of administration, administered in left arm on 03Mar2021 as dose 1, single for covid-19 immunisation. The patient concomitant medications were not reported. The patient reported, he received the second dose on 24Mar2021 and wanted to know if he should be feeling pain constantly. He is feeling pain in left arm and shoulder every day, it's pain and soreness. It feels like someone constantly sticking him with needles and it's very difficult to sleep on the left side or move arm up and down. It feels like someone is injecting him with a needle all over again whenever he tries to sleep on left side or raise the arm over his head. The only thing he has been doing is exercises and it feels like it helps a little, but its still there. He has not had to go to the emergency room, and he had not seen a physician in regards to this. It seems like it getting worse and that's what prompted him to call. It feels like when he raise his shoulder, his shoulder bone, it feels like he can actually feel the bone in his neck on the left side like an indent, compared to the right side. The outcome of event shoulder feels like someone is constantly sticking you with needles/pain in left arm and shoulder, the left arm pain started on the same day as receiving the second dose was not recovered; for rest of events was unknown.  Information on Lot/Batch number was available. Additional information has been requested.
That night my shoulder hurt and i had a little fever.  The next day i was bedridden with a fever, body aches, and my shoulder hurt.  Better the next day and went back to work.  In the last 2 months i have had a slight headache daily, still some soreness in my arm where the shot was give, swollen joints in my hands, and a significant loss of smell and taste.  I also have less energy and my breathing is a little labored.
Fever 103.7, weakness, headache started at approximately 9pm.   Had shot approximately 12 hours prior  treated with 2 rapid release Tylenol andcool compresses for entire 24 hours   No appetite had ginger ale and toast   Next day had temp of 100 until about noon.    Ginger ale  and toast.   Mid day stomach upset and diarrhea.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021 at 10:47 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 29-Apr-2021 at 10:47 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 26.24 No concomitant medications were reported. On 29-Apr-2021 at 10:00 A.M., the temperature recorded was 33 degree Fahrenheit and vial was initially moved to the fridge on 19-Apr-2021 and beyond use date was 19-May-2021. Product moved to clinic on 29-Apr-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  No treatment medications were reported.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Mar2021 as dose 1, single (Lot number: EN6208), in right arm, on 05Apr2021 as dose 2, single (Lot number: EP7534), in right arm and on 29Nov2021 as dose 3 (booster), single (Lot number: FH8030) at the age of 61 years, in right arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: indication=Treatment of COVID-19; (28Sep2022) Positive, notes: this was my 1st positive COVID test on 28Sep2022. Therapeutic measures were taken as a result of vaccination failure, covid-19.
The patient received adult dose of COVID booster, instead of 5-11 yr. olds.
Onset of new severe neurological symptoms, include intermittent partial paralysis of legs, loss of ability to speak and think, and tremor on right side of body. Symptoms started in April 2021 shortly after shot and have continued to get progressively worse since then.
Per client the erythema and edema started the day she received the injection. The area today measures 4 inches by 3 inches in width. Area is very warm to touch and per client is tender to touch.  Client has not done anything about the area other than watch it and then called Health Department today to come in. Injection was given on 12/07/2017. Instructed client to apply cool compresses to area 3 to 4 times per day and to go to urgent care if symptoms worsen. Today BP- 124/70, P- 84, R- 20, Temp- 97.7.
blood pressure was high; vaccine effected memory; woke up sick again; body pain/muscle pain; chills; heart palpitation; pain in throat; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (blood pressure was high), MEMORY IMPAIRMENT (vaccine effected memory), PALPITATIONS (heart palpitation), OROPHARYNGEAL PAIN (pain in throat) and ILLNESS (woke up sick again) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma (Athletic asthma).   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced PALPITATIONS (heart palpitation), OROPHARYNGEAL PAIN (pain in throat), MYALGIA (body pain/muscle pain) and CHILLS (chills). On 07-Mar-2021, the patient experienced ILLNESS (woke up sick again). On an unknown date, the patient experienced HYPERTENSION (blood pressure was high) and MEMORY IMPAIRMENT (vaccine effected memory). At the time of the report, HYPERTENSION (blood pressure was high), MEMORY IMPAIRMENT (vaccine effected memory), PALPITATIONS (heart palpitation), OROPHARYNGEAL PAIN (pain in throat), ILLNESS (woke up sick again), MYALGIA (body pain/muscle pain) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Mar-2021, Heart rate: abnormal (abnormal) abnormal..         No concomitant drugs were reported. No treatment information was reported.
Lump in the left upper arm, fever 101 the day after, vomiting the day after.
fever 103.5 taking motrin/ Tylenol every 4-6 hours
severe headache; muscle pain; This is a spontaneous report from a non-contactable consumer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date, the patient experienced severe headache and muscle pain. The reporter was asking if she should get her second dose of vaccine if she had experienced severe headache and muscle pain. Clinical outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
black eye; This spontaneous case was reported by a consumer and describes the occurrence of EYE CONTUSION (black eye) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced EYE CONTUSION (black eye). At the time of the report, EYE CONTUSION (black eye) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  Patient reported that she did not take any medication for the black eye and that there was nothing to add for further follow up.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Event outcome updated.
pericarditis; This is a literature report. This author reported four reports for different patients with different events. This is third of four reports.  The patient was a 21-year-old woman with a history of idiopathic thrombocytopenic purpura, who presented three weeks after her first dose of the Pfizer-BioNTech vaccine with chest pain that worsened during inspiration and while supine. She was found to have sinus tachycardia, a small pericardial effusion on echocardiogram, and elevated inflammatory markers without evidence of myocardial injury. Based on the clinical presentation, the patient was diagnosed with pericarditis. Her symptoms improved significantly with initiation of colchicine. Long-term follow-up of patients with cardiovascular events following the receipt of mRNAbased COVID-19 vaccines is needed. At the time of publication, all patients presented in this case series demonstrated clinical improvement. Author report the first case series of patients with myocarditis, stress cardiomyopathy, and pericarditis after receiving the mRNA-based COVID-19 vaccines. While we cannot definitively prove association of the vaccines with these adverse events, we believe reporting these complications may enable further monitoring and investigation. However, it is crucial to emphasize that these findings are rare while SARS-CoV-2 infection is associated with a much higher incidence of cardiovascular complications. This patient was 21-year-old Female. Viral serologies: SARS-CoV-2, HIV negative. Cardiac Biomarkers: Troponin T: undetectable. Inflammatory Markers: CRP: 72.6 mg/dL (reference range: less than 3 mg/dL); ESR: 9 mm/hour (reference range: less than 19 mm/hour). Transthoracic Echocardiogram: LVEF: 60%; LVIDd: 4.5 cm; Normal RV size and function; Small pericardial effusion. Cardiac MRI: Not performed. Coronary Evaluation: Not performed.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the limited information provided, the causal association between the event myocarditis and the suspect drug BNT162B2 cannot be excluded. Case will be reassessed upon receipt of follow-up information.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-202101513854 Same article/drug and different patient/event.
gradual onset of mild itching sensation in bilateral ear canals and posterior pharynx along with a tingling tongue sensation after administration of vaccine. No signs of urticaria or respiratory distress (or wheezing). Patient had no other known allergy triggers today, but did have post-nasal drip PTA. Chose to self-administer 0.3mg of epi at 1530 via her own epi-pen which she always carries with her. Post-administration all symptoms resolved, signed a release and left independently
body pain- every joint painful, high fever of 104-105 for 4 days without relief from either tylenol or advil.
Vaccinator attempted to administer vaccine lot #ER8732. Vaccine was prepared in a needle and syringe used by immunology clinic, not regularly used by the COVID-19 clinic. Needle bent and did not penetrate pt skin when vaccinator began to administer. A small amount of vaccine was wasted on pt skin. Another vaccine was obtained in needle and syringe used by COVID-19 Vaccine clinic and administered without issue.
Pregnant patient (She knew she was pregnant) receive her first dose of the vaccine; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient (She knew she was pregnant) receive her first dose of the vaccine) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Asthma and Heart disorder. Concomitant products included ACETYLSALICYLIC ACID (ASPRIN) and FOLIC ACID for an unknown indication.    On 21-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 03-Nov-2020 and the estimated date of delivery was 10-Aug-2021. On 21-Dec-2020, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient (She knew she was pregnant) receive her first dose of the vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  seventh week of the pregnancy.  On 21-Dec-2020, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient (She knew she was pregnant) receive her first dose of the vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported.  This is a case of product exposure during pregnancy with no associated AEs for this 24-year-old female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jan-2021: Internal review on 23-Jul-2021 resulted in updates to the pregnancy details.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 24-year-old female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
Symptomatic 1/8/2021 and tested positive for COVID 1/9/2021. Symptoms include sore throat.  No know exposures
Failed to ovulate 1 month after second Covid vaccination. Resumed normal cycle 1 month later. Recent blood work shows normal hormone levels, which would not suggest underlying issue.